Sanofi India Analysis (March 2026) | Price Development & Price Target

Sanofi India

BSE:500674

Rp 3.318,05

Rp0,00 (0,00%)

3.318,05 Rp

Rp0,00 (0,00%)

End-of-day quote: 03/27/2026

Sanofi India Stock Value

The analyst rating for BSE:500674 is currently Outperform.

Outperform

Sanofi India Company Info

EPS Growth 5Y

-5,61%

Market Cap

Rp76,42 B

Long-Term Debt

Rp0,00 B

Quarterly earnings

04/30/2026 (E)

Dividend

Rp95,89

Dividend Yield

2,89%

Founded

1956

Industry

Health Care

Country

India

Website

Sanofi India

ISIN Number

INE058A01010

Website

http://www.sanofiindialtd.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp4.800,00

44.66%

Last Update: 03/28/2026

Analysts: 3

Highest Price Target Rp5.550,00

Average Price Target Rp4.800,00

Lowest Price Target Rp4.487,00

In the last five quarters, Sanofi India’s Price Target has fallen from Rp14.236,73 to Rp8.611,80 - a -39,51% decrease. Two analysts predict that Sanofi India’s share price will increase in the coming year, reaching Rp4.800,00. This would represent an increase of 44,66%.

Top growth stocks in the health care sector (5Y.)

What does Sanofi India do?

Sanofi India Limited engages in the research, development, manufacturing, and distribution of medicines. Business Segments The company operates through segments: pharmaceutical products, vaccines, consumer healthcare, and specialty products. Pharmaceutical Products This segment develops and produces innovative prescription medications that address chronic and acute diseases. This segment covers major therapeutic categories, including diabetes, cardiovascular health, oncology, and central ner...

Sanofi India Limited engages in the research, development, manufacturing, and distribution of medicines.

Business Segments

The company operates through segments: pharmaceutical products, vaccines, consumer healthcare, and specialty products.

Pharmaceutical Products

This segment develops and produces innovative prescription medications that address chronic and acute diseases. This segment covers major therapeutic categories, including diabetes, cardiovascular health, oncology, and central nervous system disorders.

Vaccines

This segment emphasizes preventive healthcare through the development and distribution of immunizations. Its commitment to vaccine advancements underscores the importance of immunization in promoting health equity and safeguarding populations.

Consumer Healthcare

This segment encompassing over-the-counter products that cater to everyday health needs. This range includes self-care solutions, pain relief, allergy management, and nutritional supplements, empowering consumers to take charge of their health and wellness.

Specialty Products

This segment addresses niche therapeutic areas, including rare diseases and complex conditions, reinforcing the company's commitment to innovation and expanding access to specialized treatments.

Business Strategy

The company's business strategy is predicated on several foundational pillars aimed at driving sustainable growth while delivering on the commitment to enhance patient care. The company focuses on long-term value creation by fostering an innovative environment that emphasizes research and development, efficient operational practices, and market responsiveness.

Innovation is at the heart of the company’s strategy, with substantial investments directed toward developing pioneering medicines and therapies that meet the ever-changing healthcare landscape.

The company also places a strong emphasis on patient-centric approaches, ensuring that products and services resonate with the needs of patients and healthcare providers.

Finally, the company remains committed to sustainability and corporate social responsibility, embedding these principles throughout its operations.

Products and Services

The company offers a vast array of products and services designed to address various healthcare needs. The flagship portfolio comprises prescription medications that treat a diverse range of health conditions, including serious ailments such as cancer, diabetes, and cardiovascular diseases. Each product is underpinned by extensive research and clinical trials, ensuring efficacy and safety for patients.

In addition to pharmaceuticals, the vaccines segment showcases the company’s commitment to preventive healthcare. The company develops and distributes vaccines that protect against infectious diseases, strengthening community health and preventing outbreaks. The vaccines cater to various demographics, ensuring inclusive healthcare approaches.

The consumer healthcare segment features over-the-counter products, enabling individuals to manage their health autonomously. This segment includes a selection of well-known brands that address common health issues, empowering consumers through easy-to-access solutions that promote well-being.

The company’s specialty products cover niche therapeutic areas and aim to provide solutions for complex health conditions often overlooked by mainstream healthcare. This range of products underscores the importance of targeted therapies and enhances the company's capabilities in addressing rare and challenging health conditions.

Geographical Markets Served

The company serves a diverse geographical market, with a focus on expanding its reach and accessibility to patients across India and other markets. The company has established a strong presence in India, where it derives a significant portion of its revenue. Additionally, the company has extended its operations to various international markets, including Singapore and additional regions, enhancing its global footprint.

Customers

The company serves a varied customer base, comprising healthcare professionals, hospitals, clinics, and individual patients. The company employs a multifaceted approach to customer engagement, ensuring that healthcare providers have access to the latest information on product efficacy, safety, and application.

The integration of feedback mechanisms and ongoing consultations with healthcare professionals facilitates a deeper understanding of customer needs, enhancing the company’s ability to provide tailored healthcare solutions.

Modes of Sales and Marketing/Distribution Channels

The company employs a multifaceted sales and marketing strategy that integrates direct sales, partnerships, and digital marketing avenues. By leveraging a network of healthcare professionals and distributors, the company ensures efficient product delivery and widespread accessibility.

Digital marketing initiatives and educational programs underscore the company’s commitment to empowering healthcare providers with the information necessary to make informed decisions, while also directly engaging with consumers through targeted campaigns.

History

The company was founded in 1956. The company was incorporated in 1956. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in 2012.

Sanofi India Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Sales:** 100% (2026) **TOP 3 Markets:** 1. **India:** approximately 70% 2. **Southeast Asia:** approximately 15% 3. **Middle East and Africa:** approximately 10% Sanofi India Limited generates its sales entirely from the pharmaceutical industry, with the Indian market accounting f...

At which locations are the company’s products manufactured?

**Production Sites:** Goa and Ankleshwar, India Sanofi India Limited mainly produces its pharmaceutical products at two major production facilities in India. The first one is located in Goa, while the second one is in Ankleshwar, Gujarat. These sites are strategically chosen to efficiently serve bo...

What strategy does Sanofi India pursue for future growth?

**Revenue Growth:** Estimated 8-10% annually (2026) **Focus on Research and Development:** Increase in R&D spending by 15% (2026) Sanofi India Limited pursues a growth strategy that heavily emphasizes innovation and expansion into new markets. A key component of this strategy is the increased i...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), excipients **Countries of origin:** China, Germany, USA Sanofi India Limited mainly imports active pharmaceutical ingredients (APIs) and excipients needed for the production of their medications. A significant portion of these raw m...

How strong is the company’s competitive advantage?

**Market share in India:** 3.5% (2025, estimated) **R&D investments:** 8% of revenue (2025) **EBITDA margin:** 22% (2025) Sanofi India Limited has a significant competitive advantage in the Indian pharmaceutical market, supported by several factors. The 3.5% market share indicates that th...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** Approximately 45% (estimated for 2026 based on historical trends) **Insider Buys/Sells:** No significant transactions in the last 12 months (estimated for 2026) The institutional investor share in Sanofi India Limited typically ranges from about 40-50%, based on h...

What percentage market share does Sanofi India have?

**Market share of Sanofi India Limited:** Estimated 5-7% (2026) **Top competitors and their market shares:** 1. Sun Pharmaceutical Industries Ltd.: 8-10% 2. Dr. Reddy's Laboratories Ltd.: 7-9% 3. Cipla Ltd.: 6-8% 4. Lupin Ltd.: 5-7% 5. Aurobindo Pharma Ltd.: 4-6% 6. Sanofi India Limited: 5-7%...

Is Sanofi India stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **Profit Growth:** 7.2% (2025) **R&D Expenses:** 6.8% of revenue (2025) Sanofi India Limited recorded a revenue growth of 8.5% in 2025. This indicates solid demand for their products, especially in a competitive market environment. The profit growth of 7.2% shows...

Does Sanofi India pay a dividend – and how reliable is the payout?

**Dividend Yield:** 3.5% (estimated for 2026) **Dividend History:** Continuous payout over the last 5 years Sanofi India Limited has pursued a stable dividend policy in recent years. The company has regularly distributed dividends, indicating a reliable dividend policy. The estimated dividend yie...

New support ticket

Explore

Sanofi India Stock Value

Sanofi India Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Sanofi India do?

Sanofi India Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Sanofi India Stock Value

Sanofi India Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Sanofi India do?

Sanofi India Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.